Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

YL-109

YL-109 is a novel anticancer agent which has ability to inhibit breast Y cell growth and invasiveness in vitro and in vivo.

Product Specifications

CAS Number

36341-25-0

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

257.31

Molecular Formula

C14H11NO2S

Notes

Research use only, not for human use.

Receptor

AhR

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Laminin β-1 siRNA (m)
sc-35781 10 µM

Laminin β-1 siRNA (m)

Ask
View Details
Mouse Smyd5 Pre-designed siRNA Set A
SI113476A 1 Each

Mouse Smyd5 Pre-designed siRNA Set A

Ask
View Details
Neutrophil defensin 4 (DEFA4) Human Gene Knockout Kit (CRISPR)
KN413236 1 Kit

Neutrophil defensin 4 (DEFA4) Human Gene Knockout Kit (CRISPR)

Ask
View Details
W/W046/NL437/PP-297X420-1 Marine & IMO Signs (No Adhesive)
300741 1 Pack (1 Panel (s) x 1 Pack)

W/W046/NL437/PP-297X420-1 Marine & IMO Signs (No Adhesive)

Ask
View Details
TMX3 (G-5) PE
sc-515248 PE 200 µg/mL

TMX3 (G-5) PE

Ask
View Details
STARD13, ID (STARD13, DLC2, GT650, StAR-related lipid transfer protein 13, 46H23.2, Deleted in liver cancer 2 protein, Rho GTPase-activating protein, START domain-containing protein 13) (MaxLight 750)
MBS6351761-01 0.1 mL

STARD13, ID (STARD13, DLC2, GT650, StAR-related lipid transfer protein 13, 46H23.2, Deleted in liver cancer 2 protein, Rho GTPase-activating protein, START domain-containing protein 13) (MaxLight 750)

Ask
View Details